Nothing Special   »   [go: up one dir, main page]

HUE052087T2 - Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények - Google Patents

Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények

Info

Publication number
HUE052087T2
HUE052087T2 HUE17863293A HUE17863293A HUE052087T2 HU E052087 T2 HUE052087 T2 HU E052087T2 HU E17863293 A HUE17863293 A HU E17863293A HU E17863293 A HUE17863293 A HU E17863293A HU E052087 T2 HUE052087 T2 HU E052087T2
Authority
HU
Hungary
Prior art keywords
light chain
genetically modified
chain locus
lambda light
modified immunoglobulin
Prior art date
Application number
HUE17863293A
Other languages
English (en)
Inventor
Chunguang Guo
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HUE052087T2 publication Critical patent/HUE052087T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8518—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HUE17863293A 2016-11-04 2017-11-03 Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények HUE052087T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662417845P 2016-11-04 2016-11-04
US201762567932P 2017-10-04 2017-10-04

Publications (1)

Publication Number Publication Date
HUE052087T2 true HUE052087T2 (hu) 2021-04-28

Family

ID=62025924

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE20180508A HUE061980T2 (hu) 2016-11-04 2017-11-03 Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények
HUE17863293A HUE052087T2 (hu) 2016-11-04 2017-11-03 Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE20180508A HUE061980T2 (hu) 2016-11-04 2017-11-03 Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények

Country Status (25)

Country Link
US (2) US10820582B2 (hu)
EP (3) EP4082334A1 (hu)
JP (4) JP6884860B2 (hu)
KR (4) KR102319069B1 (hu)
CN (2) CN114369157A (hu)
AU (2) AU2017391167B2 (hu)
BR (1) BR112019008675A2 (hu)
CA (1) CA3038720A1 (hu)
CY (1) CY1123491T1 (hu)
DK (2) DK3407709T3 (hu)
ES (2) ES2823305T3 (hu)
HR (2) HRP20220888T1 (hu)
HU (2) HUE061980T2 (hu)
IL (2) IL308197A (hu)
LT (2) LT3766343T (hu)
MA (2) MA44091A (hu)
MX (2) MX2019005256A (hu)
PL (2) PL3407709T3 (hu)
PT (2) PT3407709T (hu)
RS (2) RS60886B1 (hu)
RU (2) RU2021129958A (hu)
SG (2) SG10201913483XA (hu)
SI (2) SI3766343T1 (hu)
SM (2) SMT202000558T1 (hu)
WO (1) WO2018128691A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881084B2 (en) 2010-07-26 2021-01-05 Trianni, Inc Transgenic animals and methods of use
US10662256B2 (en) 2010-07-26 2020-05-26 Trianni, Inc. Transgenic mammals and methods of use thereof
SI3597038T1 (sl) * 2012-02-01 2021-07-30 Regeneron Pharmaceuticals, Inc. Humanizirani glodalci, ki izražajo težke verige, ki vsebujejo domene VL
US10813346B2 (en) 2015-12-03 2020-10-27 Trianni, Inc. Enhanced immunoglobulin diversity
SG10201913483XA (en) 2016-11-04 2020-03-30 Regeneron Pharma Non-human animals having an engineered immunoglobulin lambda light chain locus
CA3093995A1 (en) 2018-03-24 2019-10-03 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof
CA3093850A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
IL305557A (en) 2018-06-14 2023-10-01 Regeneron Pharma Non-human animals capable of engineered dh-dh rearrangement and uses thereof
SG11202107589PA (en) 2019-02-22 2021-08-30 Regeneron Pharma Rodents having genetically modified sodium channels and methods of use thereof
WO2021003152A1 (en) * 2019-07-01 2021-01-07 Trianni, Inc. Transgenic mammals and methods of use thereof
EP4211155A1 (en) 2020-09-11 2023-07-19 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
WO2022132943A1 (en) 2020-12-16 2022-06-23 Regeneron Pharmaceuticals, Inc. Mice expressing humanized fc alpha receptors
WO2022140219A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
AU2021409906A1 (en) 2020-12-23 2023-06-15 Regeneron Pharmaceuticals, Inc. Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same
GB202217978D0 (en) * 2022-11-30 2023-01-11 Petmedix Ltd Rodents expressing a common light chain

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3328493A (en) * 1991-12-17 1993-07-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2003047336A2 (en) 2001-11-30 2003-06-12 Abgenix, Inc. TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES
CN103205436B (zh) * 2003-07-15 2016-05-25 人类多克隆治疗公司 人源化免疫球蛋白基因座
SI2041177T1 (sl) 2006-06-02 2012-03-30 Regeneron Pharma Visoko afinitetna protitelesa za humani IL receptor
DK2346994T3 (da) 2008-09-30 2022-02-28 Ablexis Llc Knock-in-mus til fremstilling af kimære antistoffer
CN102292445A (zh) * 2008-12-18 2011-12-21 伊拉兹马斯大学鹿特丹医学中心 表达人源化抗体的非人转基因动物及其用途
NZ597481A (en) * 2009-07-08 2013-10-25 Kymab Ltd Animal models and therapeutic molecules
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
SMT201900241T1 (it) * 2010-06-22 2019-05-10 Regeneron Pharma Topi esprimenti una catena leggera ibrida di immunoglobulina con una regione variabile umana
SI4067496T1 (sl) 2011-02-25 2023-07-31 Regeneron Pharmaceuticals, Inc. Miši ADAM6
KR20140082824A (ko) 2011-10-17 2014-07-02 리제너론 파아마슈티컬스, 인크. 제한된 면역글로불린 중쇄 마우스
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
CA2859408C (en) * 2011-12-20 2020-06-16 Regeneron Pharmaceuticals, Inc. Humanized light chain mice
ES2678221T3 (es) * 2013-02-20 2018-08-09 Regeneron Pharmaceuticals, Inc. Animales no humanos con secuencias de cadena pesada de inmunoglobulina modificadas
EP2958990B1 (en) 2013-02-20 2019-10-16 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
US9788534B2 (en) * 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
SG10201802295XA (en) * 2013-10-01 2018-04-27 Kymab Ltd Animal Models and Therapeutic Molecules
KR101773782B1 (ko) 2013-12-11 2017-09-01 리제너론 파마슈티칼스 인코포레이티드 게놈의 표적화된 변형을 위한 방법 및 조성물
SG10201913804WA (en) 2014-06-06 2020-03-30 Regeneron Pharma Methods and compositions for modifying a targeted locus
PL3155099T3 (pl) 2014-06-23 2018-08-31 Regeneron Pharmaceuticals, Inc. Łączenie dna mediowane nukleazą
IL301900A (en) 2014-11-21 2023-06-01 Regeneron Pharma Methods and compositions for targeted genetic modification using paired guide rnas
KR102530821B1 (ko) 2014-12-19 2023-05-10 리제너론 파마슈티칼스 인코포레이티드 단일 단계 다중 표적화를 통한 표적화된 유전자 변형을 위한 방법 및 조성물
SG10201913483XA (en) 2016-11-04 2020-03-30 Regeneron Pharma Non-human animals having an engineered immunoglobulin lambda light chain locus

Also Published As

Publication number Publication date
WO2018128691A8 (en) 2019-02-28
SI3766343T1 (sl) 2022-06-30
RU2021129958A (ru) 2021-11-02
RU2757665C2 (ru) 2021-10-20
IL266282B2 (en) 2024-04-01
IL266282A (en) 2019-06-30
LT3766343T (lt) 2022-06-10
DK3766343T3 (da) 2022-06-20
PL3766343T3 (pl) 2022-09-26
EP3407709A1 (en) 2018-12-05
IL308197A (en) 2024-01-01
MX2021010556A (es) 2021-10-01
EP3407709B9 (en) 2021-10-06
KR102492433B1 (ko) 2023-01-30
HRP20201403T1 (hr) 2020-11-27
PT3407709T (pt) 2020-08-20
KR20210134059A (ko) 2021-11-08
DK3407709T3 (da) 2020-08-31
WO2018128691A1 (en) 2018-07-12
CY1123491T1 (el) 2022-03-24
JP2020501516A (ja) 2020-01-23
JP2022130725A (ja) 2022-09-06
ES2915609T3 (es) 2022-06-23
EP4082334A1 (en) 2022-11-02
EP3407709B1 (en) 2020-07-29
SG11201903344XA (en) 2019-05-30
KR20240055863A (ko) 2024-04-29
SG10201913483XA (en) 2020-03-30
KR102319069B1 (ko) 2021-11-01
MX2019005256A (es) 2019-08-05
SMT202200259T1 (it) 2022-07-21
PL3407709T3 (pl) 2021-01-11
RU2019112589A3 (hu) 2021-03-30
RS60886B1 (sr) 2020-11-30
US20210029978A1 (en) 2021-02-04
MA44091A (fr) 2018-10-24
BR112019008675A2 (pt) 2019-07-09
EP3766343A1 (en) 2021-01-20
EP3766343B1 (en) 2022-05-11
CN109996441B (zh) 2022-02-08
CN109996441A (zh) 2019-07-09
US20180125043A1 (en) 2018-05-10
JP2021090455A (ja) 2021-06-17
IL266282B1 (en) 2023-12-01
JP7386292B2 (ja) 2023-11-24
AU2024200582A1 (en) 2024-03-28
CA3038720A1 (en) 2018-07-12
KR20190076024A (ko) 2019-07-01
JP2023053400A (ja) 2023-04-12
KR102658529B1 (ko) 2024-04-19
RU2019112589A (ru) 2020-12-04
RS63390B1 (sr) 2022-08-31
SMT202000558T1 (it) 2020-11-10
ES2823305T3 (es) 2021-05-06
AU2017391167B2 (en) 2024-02-15
PT3766343T (pt) 2022-05-30
HRP20220888T1 (hr) 2022-10-28
MA53935A (fr) 2021-12-22
HUE061980T2 (hu) 2023-09-28
NZ753456A (en) 2021-08-27
KR20230020550A (ko) 2023-02-10
CN114369157A (zh) 2022-04-19
SI3407709T1 (sl) 2020-10-30
LT3407709T (lt) 2020-10-12
JP6884860B2 (ja) 2021-06-09
US10820582B2 (en) 2020-11-03
AU2017391167A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
HUE061980T2 (hu) Génmódosított immunglobulin lambda könnyûlánc lókusszal rendelkezõ nem humán élõlények
DK3157956T3 (da) Ikke-humane dyr med et humaniseret gen med programmeret celledød 1
LT3597037T (lt) Humanizuoti gyvūnai, išskyrus žmones, su apribotu imunoglobulino sunkiosios grandinės lokusu
IL274797A (en) Non-human animals with engineered immunoglobulin light chain and uses thereof
HUE061977T2 (hu) Korlátozott immumglobulin könnyûlánc-repertoárt expresszáló egerek
LT2989893T (lt) Gyvūnai, išskyrus žmogų, ekspresuojantys antikūnus, turinčius bendrą lengvąją grandinę
EP3694890A4 (en) VEGFR ANTIBODY LIGHT CHAIN FUSION PROTEIN
HK1250038A1 (zh) 選擇結合抗原的輕鏈可變區的非人動物
EP3278441C0 (de) Verlustarmer modularer multilevelkonverter
IL285498A (en) Non-human animals genetically modified with a human immunoglobulin locus
DK3129400T3 (da) Ikke-humane dyr med humaniserede Fc-gamma-receptorer
DK3723858T3 (da) Fixaxfx bispecifik antistof med fælles let kæde
MA43962A (fr) Animaux non humains possédant un gène angptl8 modifié
EP3644722C0 (en) RODENTS COMPRISING AN ASGR1 LOCUS
EP3781427A4 (en) CHAIN DRIVE ELECTRO-DRIVE GEARBOX
DE102019129616A8 (de) Kettenantriebsmechanismus
DK3543423T3 (da) Bæreprofil med et kipelement
DK3611404T3 (da) Kædetandhjul
EP4182451A4 (en) SYNTHETIC N-GLYCOSYLTRANSFERASES WITH MODIFIED SPECIFICITIES
EP4007841C0 (en) IMPROVED PROFILE GEAR WHEEL
GB201820977D0 (en) Fixaxfx bispecific antibody with commomn light chain